BACKGROUND AND OBJECTIVES: Cardiovascular disease is the main cause of mortality in chronic kidney disease (CKD) patients. Vitamin D might have beneficial effects on vascular health. The aim of this study was to determine the prevalence of vitamin D deficiency (25-hydroxyvitamin D [25D] <or= 15 ng/ml) and insufficiency (25D levels between 16 and 30 ng/ml) in a cohort of patients at different CKD stages and the relationships between vitamin D serum levels, vascular calcification and stiffness, and the mortality risk. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: One hundred forty CKD patients (85 men, mean age 67 +/- 12 yr; CKD stages 2 [8%], 3 [26%], 4 [26%], 5 [7%], and 5D [(33%]) were allocated for a prospective study. Serum levels of 25D and 1,25-dihydroxyvitamin D, aortic calcification score, and pulse wave velocity (PWV) were evaluated. RESULTS: There was a high prevalence of vitamin D deficiency (42%) and insufficiency (34%). Patients with 25D <or= 16.7 ng/ml (median) had a significantly lower survival rate than patients with 25D >16.7 ng/ml (mean follow-up, 605 +/- 217 d; range, 10 to 889; P = 0.05). Multivariate adjustments (included age, gender, diabetes, arterial pressure, CKD stage, phosphate, albumin, hemoglobin, aortic calcification score and PWV) confirmed 25D level as an independent predictor of all-cause mortality. CONCLUSIONS: Vitamin D deficiency and insufficiency were highly prevalent in this CKD cohort. Low 25D levels affected mortality independently of vascular calcification and stiffness, suggesting that 25D may influence survival in CKD patients via additional pathways that need to be further explored.
BACKGROUND AND OBJECTIVES:Cardiovascular disease is the main cause of mortality in chronic kidney disease (CKD) patients. Vitamin D might have beneficial effects on vascular health. The aim of this study was to determine the prevalence of vitamin D deficiency (25-hydroxyvitamin D [25D] <or= 15 ng/ml) and insufficiency (25D levels between 16 and 30 ng/ml) in a cohort of patients at different CKD stages and the relationships between vitamin D serum levels, vascular calcification and stiffness, and the mortality risk. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: One hundred forty CKDpatients (85 men, mean age 67 +/- 12 yr; CKD stages 2 [8%], 3 [26%], 4 [26%], 5 [7%], and 5D [(33%]) were allocated for a prospective study. Serum levels of 25D and 1,25-dihydroxyvitamin D, aortic calcification score, and pulse wave velocity (PWV) were evaluated. RESULTS: There was a high prevalence of vitamin D deficiency (42%) and insufficiency (34%). Patients with 25D <or= 16.7 ng/ml (median) had a significantly lower survival rate than patients with 25D >16.7 ng/ml (mean follow-up, 605 +/- 217 d; range, 10 to 889; P = 0.05). Multivariate adjustments (included age, gender, diabetes, arterial pressure, CKD stage, phosphate, albumin, hemoglobin, aortic calcification score and PWV) confirmed 25D level as an independent predictor of all-cause mortality. CONCLUSIONS:Vitamin D deficiency and insufficiency were highly prevalent in this CKD cohort. Low 25D levels affected mortality independently of vascular calcification and stiffness, suggesting that 25D may influence survival in CKDpatients via additional pathways that need to be further explored.
Authors: Ming Teng; Myles Wolf; M Norma Ofsthun; J Michael Lazarus; Miguel A Hernán; Carlos A Camargo; Ravi Thadhani Journal: J Am Soc Nephrol Date: 2005-02-23 Impact factor: 10.121
Authors: Robert E LaClair; Richard N Hellman; Sharon L Karp; Michael Kraus; Susan Ofner; Qian Li; Karen L Graves; Sharon M Moe Journal: Am J Kidney Dis Date: 2005-06 Impact factor: 8.860
Authors: Wei Xiang; Juan Kong; Songcang Chen; Li-Ping Cao; Guilin Qiao; Wei Zheng; Wenhua Liu; Xinmin Li; David G Gardner; Yan Chun Li Journal: Am J Physiol Endocrinol Metab Date: 2004-09-14 Impact factor: 4.310
Authors: Pablo Molina; José L Górriz; Mariola D Molina; Sandra Beltrán; Belén Vizcaíno; Verónica Escudero; Julia Kanter; Ana I Ávila; Jordi Bover; Elvira Fernández; Javier Nieto; Secundino Cigarrán; Enrique Gruss; Gema Fernández-Juárez; Alberto Martínez-Castelao; Juan F Navarro-González; Ramón Romero; Luis M Pallardó Journal: World J Nephrol Date: 2016-09-06
Authors: Heidi J Kalkwarf; Michelle R Denburg; C Frederic Strife; Babette S Zemel; Debbie L Foerster; Rachel J Wetzsteon; Mary B Leonard Journal: Kidney Int Date: 2011-12-28 Impact factor: 10.612
Authors: Laura H Mariani; Matthew T White; Justine Shults; Cheryl A M Anderson; Harold I Feldman; Myles Wolf; Peter P Reese; Michelle R Denburg; Raymond R Townsend; Joan C Lo; Anne R Cappola; Dean Carlow; Crystal A Gadegbeku; Susan Steigerwalt; Mary B Leonard Journal: J Ren Nutr Date: 2014-03-07 Impact factor: 3.655
Authors: Christiane Drechsler; Stefan Pilz; Barbara Obermayer-Pietsch; Marion Verduijn; Andreas Tomaschitz; Vera Krane; Katharina Espe; Friedo Dekker; Vincent Brandenburg; Winfried März; Eberhard Ritz; Christoph Wanner Journal: Eur Heart J Date: 2010-08-05 Impact factor: 29.983
Authors: Fellype C Barreto; Daniela V Barreto; Sophie Liabeuf; Natalie Meert; Griet Glorieux; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy Journal: Clin J Am Soc Nephrol Date: 2009-08-20 Impact factor: 8.237
Authors: Luigi Francesco Morrone; Pergiorgio Bolasco; Corrado Camerini; Giuseppe Cianciolo; Adamasco Cupisti; Andrea Galassi; Sandro Mazzaferro; Domenico Russo; Luigi Russo; Mario Cozzolino Journal: J Nephrol Date: 2016-04-09 Impact factor: 3.902